Vaccines Market Research Reports & Industry Analysis
Key issues in the global vaccine market today include product safety, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems.
The topic of vaccine safety became prominent during the mid 1970’s with increases in lawsuits filed on behalf of those presumably injured by the diphtheria, pertussis, and tetanus (DPT) vaccine. To respond to public health concerns, Congress passed the National Childhood Vaccine Injury Act (NCVIA) in 1986, which in turn led to the creation of the National Vaccine Program Office (NVPO) within the Department of Health and Human Services (DHHS). NCVIA requires that all healthcare providers who administer vaccines containing diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, hepatitis B, Haemophilus influenzae type b and varicella provide a Vaccine Information Statement (VIS) to the vaccine recipient, their parent or legal guardian prior to each dose. Each VIS contains a brief description of the disease as well as the risks and benefits of the vaccine. The NCVIA also mandated that all healthcare providers report certain adverse events that occur following vaccination. As a result, the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink Project (VSD) were established in 1990. VAERS provides a mechanism for the collection and analysis of adverse events associated with vaccines currently licensed in the U.S.; VSD involved forming partnerships with four large health maintenance organizations (HMOs) to continually monitor vaccine safety. The National Vaccine Injury Compensation Program, which was also created by NCVIA, compensates those individuals who have been injured by vaccines on a no-fault basis. On a global basis, the World Health Organization (WHO) is actively involved in ensuring the quality of vaccines.
Vaccines Industry Research & Market Reports
-
Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020
... The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions. A range of players - from pharma and biotech firms ... Read More
-
COVID-19 Pipeline of Small and Mid-Cap Bio/Pharma Companies - Coronavirus Disease 2019 Sector Forecast
... PowerPoint based report gives an important expert analysis on how the developement of vaccines and therapeutics for COVID-19 has been approached by Small and Mid Cap Bio/Pharma Companies. Findings are based on the industry’s most ... Read More
-
Global Therapeutic Vaccines Market 2020-2024
... period. Our reports on therapeutic vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
China Human Vaccine Industry Report, 2020-2026
... was exposed. The impact fades away amid tighter control on human vaccines in China. In 2019, National Institutes for Food and Drug Control (NIFDC) approved 570 million doses of human vaccine with a year-on-year increase ... Read More
-
Coronavirus Disease Vaccines (COVID-19 Vaccines)
... into clinical trials. Broadly, some eight different vaccine technologies are in clinical trials: mRNA, DNA plasmid, protein subunit, adenovirus-vectored, measles-vectored, vesicular stomatitis virus-vectored, adenovirus associated-vectored and inactivated virus vaccines. Seven companies have planned or ongoing ... Read More
-
Post-pandemic Global Healthcare Market Outlook, 2020
... and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-19 pandemic and the changing economic and business scenario, Frost ... Read More
-
Fetal Bovine Serum Market Research Report by Application (Cell Culture Media, Diagnostics, Drug Discovery, Human and Animal Vaccine Production, and In Vitro Fertilization), by End User (Industry and Research & Academic Institutes) - United States Forecast
... States Forecast to 2025 - Cumulative Impact of COVID-19 The United States Fetal Bovine Serum Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have ... Read More
-
Biologics Safety Testing Market Research Report by Test Type (Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication and Characterization Tests, Endotoxin Tests, and Residual Host Contaminant Detection Tests), by Application (Blood
... Products Testing, Cellular and Gene Therapy, Stem Cell Research, Tissue and Tissue-Related Products Testing, and Vaccine & Therapeutics Development) - United States Forecast to 2025 - Cumulative Impact of COVID-19 The United States Biologics Safety ... Read More
-
COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025
... and hence the medical researchers are racing to find a solution to the pandemic. According to this latest publication from Meticulous Research®, the leading areas of research include antibodies, protein-based vaccines, antiviral, drug repurposes, RNA-based ... Read More
-
Global Nasal Spray Vaccine Market Report, History and Forecast 2015-2026
... and it is expected to reach US$ 198.26 million by the end of 2026, growing at a CAGR of 7.66% during 2020-2026. Global Nasal Spray Vaccine Scope and Market Size The global Nasal Spray Vaccine ... Read More
-
COVID-19 (Coronavirus) Global Market Conditions and Competitors: Cell Therapies, Diagnostics, Treatments, Trials, & Vaccines
... in under six months. While there is not yet an approved treatment for COVID-19, the scientific, medical and regulatory agencies are making heroic efforts to bring out new medicines. Numerous COVID-19 product categories have emerged, ... Read More
-
Global Clinical Trials of Drugs and Vaccines Market 2020 by Company, Regions, Type and Application, Forecast to 2025
... global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market ... Read More
-
Global BCG Vaccine Market (By Drug Type, End Use, Usage & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
... growing at a CAGR of 4.70% during the period spanning 2020-2024. Growth in the global BCG vaccine market was driven by factors like increasing prevalence of tuberculosis, rising R&D funding on tuberculosis, growing incidences of ... Read More
-
COVID-19 Pipelines – Cell Therapies, Diagnostics, Treatments, & Vaccines [June 2020]
... and management of the COVID–19. While there is not yet an approved treatment for COVID-19, the scientific, medical and regulatory agencies are making heroic efforts to bring out new medicines. Numerous COVID-19 product categories have ... Read More
-
Global mRNA Vaccines & Therapeutics Sales Market Report 2020
... 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect ... Read More
-
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
... countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for ... Read More
-
Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2025
... projected to grow at a CAGR of 7.2% during the forecast period (2020–2025).” The global veterinary vaccines market size is projected to reach USD 11.3 billion by 2025 from USD 8.0 billion in 2020, at ... Read More
-
COVID-19: Should A/NZ Businesses Encourage the Adoption of Contact Tracing Apps in the Workplace?
... to contain COVID-19. Focusing on the New Zealand and Australian environments the report suggests businesses could get value out of encouraging employees to use the national contact tracing app, so long as employers have done ... Read More
-
Global Avian Influenza Vaccines Market Growth 2020-2025
... combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier ... Read More
-
The COVID-19 Fallout: BCC Research Report on the R&D, Economic Impact and Future Implications
... development, and the pandemic's impact on the global economy and healthcare industry. Report Includes: - An overview of the COVID-19 (novel coronavirus disease) pandemic outbreak and its impact on the R&D, global economy and overall ... Read More
-
Vaccines Markets in China
... a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment ... Read More
-
Vaccines Industry Forecasts - China Focus
... capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is ... Read More
-
COVID-19 Impact on Vaccines & Drugs Market - Global Forecast to 2025
... vaccines market is projected to reach USD 1,401 million by 2025 from USD 2,273 million in 2022, at a CAGR of -14.9% during the forecast period. The growth of the global COVID-19 vaccines market is ... Read More
-
Vaccines Companies in China
... manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China ... Read More
-
Global Flu Vaccine Market Insights, Forecast to 2026
... reach US$ 6835.38 million by the end of 2026, with a CAGR of 4.82% during 2020-2026. Global Flu Vaccine Scope and Segment Flu Vaccine market is segmented by company, region (country), by Type, and by ... Read More
